| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-79 |
| filingDate |
1998-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23ad87a073a8e16178219fe69598f6d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0784b58af038479cebb3bdc49a1cfe08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bb557b723ea9073d7a58697f652afa7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abe4cbc975516148e3765be0e0fb050d |
| publicationDate |
2007-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2247232-C |
| titleOfInvention |
Antimicrobial composition |
| abstract |
The invention relates to antimicrobial compositions comprising a combination of vinyl-pyrrolidinone cephalosporin derivatives of the general formula I (see formula I) with carbapenem antibiotics or with .beta.-lactamase inhibitors, to the use of the compositions for producing a medicament for the treatment and prophylaxis of infectious diseases, including MRSA infections, and to pharmaceutical compositions containing the combination. |
| priorityDate |
1997-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |